This trial is active, not recruiting.

Conditions satiety, satiety responsiveness
Treatments almonds, cheese savouries
Sponsor University of Leeds
Collaborator Almond Board of California
Start date June 2015
End date November 2015
Trial size 42 participants
Trial identifier NCT02480582, LDS-2015-ABC, RG.PSYC.102933


The current study will examine the effect of almond consumption (0.9g/kg dose) compared to an energy and weight matched comparator food or no food on measures of appetite control including appetite sensations, energy intake and food hedonics.

United States No locations recruiting
Other countries No locations recruiting

Study Design

Allocation randomized
Intervention model crossover assignment
Masking single blind (subject)
Primary purpose basic science
Whole, raw almonds
(Active Comparator)
Sainsbury's savoury biscuits
cheese savouries
(No Intervention)

Primary Outcomes

Test Meal Energy Intake
time frame: 3 Weeks
24 Hour Energy Intake
time frame: 3 Weeks
Appetite Sensations
time frame: 3 Weeks
Food Preference
time frame: 3 Weeks

Eligibility Criteria

Female participants from 18 years up to 55 years old.

Inclusion Criteria: - Participants who have provided written informed consent. - Healthy female participants aged 18-55 years. - BMI of 18.5 - 30.0 kg/m2. - Regular breakfast eaters. - Not currently dieting to lose, gain or maintain weight. - Non-smokers. - Liking/acceptance of the study foods (≥4 on 7-point Likert scale). Exclusion Criteria: - Taking medication known to affect appetite within past month and/or during the study. - Any known food allergies or food intolerances. - Participants who do not regularly eat breakfast. - Participants with low liking or acceptance of the study foods. - Participants currently dieting to lose, gain or maintain weight. - Reported history of or present eating disorder. - BMI <18.5 kg/m2 or >30 kg/m2. - Vegetarians.

Additional Information

Official title The Impact of Snacks Which Vary Nutritionally in Their Satiating Potential on Measures of Appetite Control
Principal investigator Graham Finlayson, PhD
Trial information was received from ClinicalTrials.gov and was last updated in December 2015.
Information provided to ClinicalTrials.gov by University of Leeds.